Hakan Cam

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Signaling Pathway

Cell Cycle Arrest

Top Venues

Molecular cancer therapeutics

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Terry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, Karina Alagoa, Maricruz Espinoza, Hemant K Bid, Fuyang Li, Haihong Zhong, Doris A Phelps, Ryan D Roberts, Hakan Cam, Cheryl A London, Denis C Guttridge, Yidong Chen, Manjeet K Rao, Yuzuru Shiio, Peter J Houghton
Redundant Signaling as the Predominant mechanism for Resistance to Antibodies Targeting IGF-1R in Cells Derived from Childhood Sarcoma. Molecular cancer therapeutics (2023)
Terry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, Karina Alagoa, Maricruz Espinoza, Hemant K Bid, Fuyang Li, Haihong Zhong, Doris A Phelps, Ryan D Roberts, Hakan Cam, Cheryl A London, Denis C Guttridge, Yidong Chen, Manjeet K Rao, Yuzuru Shiio, Peter J Houghton
Redundant Signaling as the Predominant mechanism for Resistance to Antibodies Targeting IGF-1R in Cells Derived from Childhood Sarcoma. Molecular cancer therapeutics (2023)
Terry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, Karina Alagoa, Maricruz Espinoza, Hemant K Bid, Fuyang Li, Haihong Zhong, Doris A Phelps, Ryan D Roberts, Hakan Cam, Cheryl A London, Denis C Guttridge, Yidong Chen, Manjeet K Rao, Yuzuru Shiio, Peter J Houghton
Redundant Signaling as the Predominant mechanism for Resistance to Antibodies Targeting IGF-1R in Cells Derived from Childhood Sarcoma. Molecular cancer therapeutics (2023)
Manish Charan, Piyush Dravid, Maren Cam, Anthony Audino, Amy C Gross, Michael A Arnold, Ryan D Roberts, Timothy P Cripe, Alexander Pertsemlidis, Peter J Houghton, Hakan Cam
GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma. International journal of cancer 146 (11) (2019)